PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern medicine. The event is scheduled for 20-21 April in Amsterdam. Trust and ...

Sanofi’s Board of Directors announced Belén Garijo as the company’s next CEO following the move to not renew the tenure of ...

Sanofi sold its controlling stake in the drugmaker’s consumer-health unit last year, meaning it’s now entirely reliant on innovative prescription medicines.

Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the ...

Sanofi abruptly replaced Chief Executive Officer Paul Hudson after a massive spending boost on research and development failed to deliver rapid results, appointing Merck KGaA’s Belén Garijo to succeed ...

Sanofi is replacing Paul Hudson as CEO, amid questions about which medicines will drive the company's growth in the future.

This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...